Ressources

Inégalités d’accès et d’usage des technologies numériques : un déterminant préoccupant pour la santé de la population?

Product: — Institut national de santé publique du Québec

Barriers to Access Cost Economics Health Equity & Social Determinants of Health Health Inequities Vulnerable Sub-populations

www.inspq.qc.ca Dernière mise à jour: juillet 12, 2021

Also available in English

Pre-Operative COVID‑19 Testing and Vaccination Across Jurisdictions

Product: — Evidence Synthesis Network

Hospital Care Surgery Testing & Tracing Testing Data

esnetwork.ca Dernière mise à jour: juin 25, 2021

Strategies to Support Ontarians’ Capability, Opportunity, and Motivation for COVID‑19 Vaccination

Product: — Science Table

About Coronavirus Epidemiology Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: juin 23, 2021

Guidance and Jurisdictional Evidence Regarding The Use of Vaccine Passports

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 21, 2021

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: juin 15, 2021

Les tests de dépistage à domicile pour le coronavirus du syndrome respiratoire aigu sévère 2

Product: — Canadian Agency for Drugs and Technologies in Health

Testing & Tracing Testing Data

covid.cadth.ca Dernière mise à jour: mai 17, 2021

Also available in English

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: mai 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021